ODROWAZ ZANETA enters ATTOVIA THERAPEUTICS, INC. with 103.27K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/4/2026ACC: 0002141590-26-000006
Officer· Chief Business Officer
Since Aug 2026
103.27K
Baseline shares
100% direct
103.27K
Direct ownership
1 position
207.82K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned103.27K
Total
103.27K direct103.27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 103.27K | Direct |
| Total | 103.27K | 103.27K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
85.04K
Shares owned
N/A
Exercise price
4.9237
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
15.14K
Shares owned
N/A
Exercise price
1.5793
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
102.26K
Shares owned
N/A
Exercise price
3.5302
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
5.38K
Shares owned
N/A
Exercise price
2.8799
Expiration
—
Exercise window
—
Total
Underlying
207.82K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 4.9237 | — | — | 85.04K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 1.5793 | — | — | 15.14K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.5302 | — | — | 102.26K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 2.8799 | — | — | 5.38K | N/A |
| Total | 207.82K | 0.00 | ||||